Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients – insights on the risk of acquisition and CRE infection

References

• Aguado JM, Silva JT, Fernández-Ruiz M, Spanish Network for Research in Infectious Diseases (REIPI) (RD16/0016), et al. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. Transplant Rev. 2018;32(1):36–57.
   Web of Science ®Google Scholar
• Gutiérrez-Gutiérrez B, Salamanca E, de Cueto M, et al. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis. 2017;3099(17):1–9.
   Google Scholar
• Pouch SM, Satlin MJ. Carbapenem-resistant Enterobacteriaceae in special populations: solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies. Virulence. 2017;8(4):312–391.
   Web of Science ®Google Scholar
• Giannella M, Bartoletti M, Campoli C, et al. The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study. Clin Microbiol Infect. 2019;25(12):1525–1531.
   PubMed Web of Science ®Google Scholar
• Cicora F, Mos F, Paz M, et al. Infections with blaKPC-2-producing Klebsiella pneumoniae in renal transplant patients: A retrospective study. Transplant Proc. 2013;45(9):3389–3393.
   PubMed Web of Science ®Google Scholar
• Freire MP, Abdala E, Moura ML, et al. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients. Infection. 2015;43(3):315–323.
   PubMed Web of Science ®Google Scholar
• Huprikar S, Casner L, Camera Pierrotti L, et al. CDC/NHSN surveillance definitions for specific types of infections [Internet], p. 17-1–17-29.; 2017 [cited 2017 Jan 6]. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf.
   Google Scholar
• EUCAST. European Committee on antimicrobial susceptibility testing breakpoint tables for interpretation of MICs and zone diameters European Committee on antimicrobial susceptibility testing breakpoint tables for interpretation of MICs and zone diameters; 2018. p. 0–77. Available from: https://www.eucast.org/clinical_breakpoints/
   Google Scholar
• CLSI. Performance standards for antimicrobial susceptibility testing. 27th ed. (CLSI supplement M100). Wayne, PA: Clinical and Laboratory Standards Institute; 2017. p. 282.
   Google Scholar
• Huprikar S, Casner L, Camera L, et al. PG. Outcomes associated with carbapenem-resistant enterobacteriaceae infection after solid organ transplantation in a multicenter study. [abstract]. Am J Transpl. 2016;16: 403.
   Web of Science ®Google Scholar
• Varotti G, Dodi F, Terulla A, et al. Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation. Transpl Infect Dis. 2017;19(6):e12757–e12758.
   Web of Science ®Google Scholar
• Varotti G, Dodi F, Terulla A, et al. Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation. Transpl Infect Dis. 2017;19(6):e12757.
   Google Scholar
• Freire MP, Oshiro ICVS, Pierrotti LC, et al. Carbapenem-resistant Enterobacteriaceae acquired before liver transplantation: impact on recipient outcomes. Transplantation. 2017;101(4):811–820.
   PubMed Web of Science ®Google Scholar
• Zimmerman FS, Assous MV, Bdolah-Abram T, et al. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control. 2013;41(3):190–194.
   PubMed Web of Science ®Google Scholar
• Macesic N, Gomez-Simmonds A, Sullivan SB, et al. Genomic surveillance reveals diversity of multidrug-resistant organism colonization and infection: a prospective cohort study in liver transplant recipients. Clin Infect Dis. 2018;67(6):905–912.
   PubMed Web of Science ®Google Scholar
• Simkins J, Muggia V, Cohen HW, et al. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study. Transpl Infect Dis. 2014;16(5):775–782.
   PubMed Web of Science ®Google Scholar
• Rodrigues dos Santos BG, Amaral ES, Fernandes P, et al. Urinary tract infections and surgical site infections due to carbapenem-resistant Enterobacteriaceae in renal transplant. Transplant Proc. 2016;48(6):2050–2055.
   PubMed Web of Science ®Google Scholar
• Mularoni A, Martucci G, Douradinha B, et al. Epidemiology and successful containment of a carbapenem‐resistant Enterobacteriaceae outbreak in a Southern Italian Transplant Institute. Transpl Infect Dis. 2019;21(4):e13119.
   PubMed Web of Science ®Google Scholar
• San-Juan R, Fernández-Ruiz M, Ruiz-Ruigómez M, et al. A new clinical and immuno-virological score for predicting the risk of late severe infection in solid organ transplant recipients: the CLIV Score. J Infect Dis. 2020;222(3):479–487.
   PubMed Web of Science ®Google Scholar
• Pérez-Nadales E, Gutiérrez-Gutiérrez B, Natera AM, et al. Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: the impact of cytomegalovirus disease and lymphopenia. Am J Transplant. 2019;(June 2019):1–13.
   Google Scholar
• Freire MP, de Oliveira Garcia D, Cury AP, et al. The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae. Eur J Clin Microbiol Infect Dis. 2019;38(4):755–765.
   PubMed Web of Science ®Google Scholar
• Dong N, Yang X, Zhang R, et al. Tracking microevolution events among ST11 carbapenemase-producing hypervirulent Klebsiella pneumoniae outbreak strains. Emerg Microbes Infect. 2018;7(1):111–146.
   PubMedGoogle Scholar
• Freire MP, de Oliveira Garcia D, Cury AP, et al. Outbreak of IMP-producing carbapenem-resistant Enterobacter gergoviae among kidney transplant recipients. J Antimicrob Chemother. 2016;71(9):2577–2585.
   PubMed Web of Science ®Google Scholar
• Wu X, Dong Y, Liu Y, et al. The prevalence and predictive factors of urinary tract infection in patients undergoing renal transplantation: a meta-analysis. Am J Infect Control. 2016;44(11):1261–1268.
   PubMed Web of Science ®Google Scholar
• Freire MP, Mendes CV, Piovesan AC, et al. Does the urinary tract infection caused by carbapenem-resistant Gram-negative bacilli impact the outcome of kidney transplant recipients? Transpl Infect Dis. 2018;20(4):e12923.
   PubMed Web of Science ®Google Scholar
• Neff RT, Jindal RM, Yoo DY, et al. Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia. Transplantation. 2009;88(1):135–141.
   PubMed Web of Science ®Google Scholar